Selective inhibition of MDR1 P-glycoprotein mediated transport by the acridone carboxamide derivative GG918

British Journal of Cancer

Volumn 79, Issue 7-8, 1999, Pages 1053-1060

  Wallstab, A ^a   Koester, M ^a   Bohme M ^a   Keppler, D ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

ATP dependent transport; GG918 (formerly GF120918); Multidrug resistance (MDR); P glycoprotein; Transport inhibition

Indexed keywords

ACRIDONE DERIVATIVE; AMIDE; AZIDOPINE; DAUNORUBICIN; ELACRIDAR; GLYCOPROTEIN P; LEUKOTRIENE; MULTIDRUG RESISTANCE PROTEIN; TAUROCHOLIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL MEMBRANE; MALE; MEMBRANE VESICLE; NONHUMAN; PRIORITY JOURNAL; RAT;

ACRIDINES; ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; AZIDES; BILE; DAUNORUBICIN; DIHYDROPYRIDINES; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; ISOQUINOLINES; LIVER; MALE; NEOPLASM PROTEINS; ORGANELLES; P-GLYCOPROTEIN; PHOTOAFFINITY LABELS; RATS; RATS, WISTAR; TAUROCHOLIC ACID; TETRAHYDROISOQUINOLINES;

EID: 0033052443     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690169     Document Type: Article

References (43)

1. Adachi Y, Kobayashi H, Kurumi Y, Shouji M, Kitano M and Yamamoto T (1991) ATP-dependent taurocholate transport by rat liver canalicular membrane vesicles. Hepatology 14: 655-659
2. Böhme M, Büchler M, Müller M and Keppler D (1993) Differential inhibition by cyclosporins of primary-active ATP-dependent transporters in the hepatocyte canalicular membrane. FEBS Lett 333: 193-196
3. Böhme M, Jedlitschky G, Leier I, Büchler M and Keppler D (1994a) ATP-dependent export pumps and their inhibition by cyclosporins. Adv Enzyme Regul 34: 371-380
4. Böhme M, Müller M, Leier I, Jedlitschky G and Keppler D (1994b) Cholestasis caused by inhibition of the adenosine triphosphate-dependent bile salt transport in rat liver. Gastroenterology 107: 255-265
5. Boesch D, Gaveriaux C, Jachez B, Pourtier-Manzanedo A, Bollinger P and Loor F (1991) In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833. Cancer Res 51: 4226-4233
6. Brown PC, Thorgeirsson SS and Silverman JA (1993) Cloning and regulation of the rat mdr2 gene. Nucleic Acids Res 21: 3885-3891
7. Büchler M, Böhme M, Ortlepp H and Keppler D (1994) Functional reconstitution of ATP-dependent transporters from the solubilized hepatocyte canalicular membrane. Eur J Biochem 224: 345-352
8. Dantzig AH, Shepard RL, Cao J, Law KL, Ehlhardt, WJ, Baughman TM, Bumol TF and Starling JJ (1996) Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979. Cancer Res 56: 4171-4179
9. Denzlinger C, Rapp S, Hagmann W and Keppler D (1985) Leukotrienes as mediators in tissue trauma. Science 230: 330-332
10. Devault A and Gros P (1990) Two members of the mouse mdr family confer drug resistance with overlapping but distinct drug specificities. Mol Cell Biol 10: 1652-1663
11. Ford JM and Hait WN (1990) Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol Rev 42: 155-199
12. Ford JM, Prozialeck W and Hait WN (1989) Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance. Mol Pharmacol 35: 105-115
13. Gerloff T, Stieger B, Hagenbuch B, Madon J, Landmann L, Roth J, Hofmann AF and Meier PJ (1998) The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem 273: 10046-10050
14. Gottesman MM and Pastan I (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62: 385-427
15. Gros P, Raymond M, Bell J and Housman D (1988) Cloning and characterization of a second member of the mouse mdr gene family. Mol Cell Biol 8: 2770-2778
16. Guhlmann A, Krauss K, Oberdorfer F, Siegel T, Scheuber PH, Müller J, Csuk-Glänzer B, Ziegler S, Ostertag H and Keppler D (1995) Noninvasive assessment of hepatobiliary and renal elimination of cysteinyl leukotrienes by positron emission tomography. Hepatology 21: 1568-1575
17. Hait WN and Aftab DT (1992) Rational design and pre-clinical pharmacology of drugs for reversing multidrug resistance. Biochem Pharmacol 43: 103-107
18. Hyafil F, Vergely C, Du Vignaud P and Grand-Perret T (1993) In vitro and in vivo reversal of multidrug resistance by GF120918, an acridone carboxamide derivative. Cancer Res 53: 4595-4602
19. Ishikawa T, Müller M, Klünemann C, Schaub T and Keppler D (1990) ATP-dependent primary active transport of cysteinyl leukotrienes across the liver canalicular membrane. Role of the ATP-dependent transport system for glutathione S-conjugates. J Biol Chem 265: 19279-19286
20. Juliano RL and Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochem Biophys Acta 455: 152-162
21. Kadmon M, Klünemann C, Böhme M, Ishikawa T, Gorgas K, Otto G, Herfarth C and Keppler D (1993) Inhibition by cyclosporin A of adenosine triphosphate-dependenl transport from the hepatocyte into bile. Gastroenterology 104: 1507-1514
22. Kamimoto Y, Gatmaitan Z, Hsu J and Arias IM (1989) The function of the Gp170, the multidrug resistance gene product, in rat liver canalicular membranes. J Biol Chem 264: 11693-11698
23. Keppler D and König J (1997) Expression and localization of the conjugate export pump encoded by the MRP2 (cMRP/cMOAT) gene in liver. FASEB J 11: 509-616
24. Keppler D, Jedlitschky G and Leier I (1998) Transport function and substrate specificity of multidrug resistance protein. Methods Enzymol 292: 607-616
25. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685
26. 4 export carrier in mastocytoma cells. Eur J Biochem 220: 599-606
27. Lin MC, Kramer W and Wilson FA (1990) Identification of cytosolic and microsomal bile acid-binding proteins in rat ileal enterocytes. J Biol Chem 265: 14986-14990
28. Loe DW, Deeley RG and Cole SPC (1996) Biology of the multidrug resistance-associated protein, MRP. Eur J Cancer 32A: 945-957
29. Meier PJ and Boser JL (1990) Preparation of basolateral (sinusoidal) and canalicular plasma membrane vesicles for the study of hepatic transport processes. Methods Enzymol 192: 534-545
30. Müller M, Ishikawa T, Berger U, Klünemann C, Lucka L, Schreyer A, Kannicht C, Reutter W, Kurz G and Keppler D (1991) ATP-dependent transport of taurocholate across the hepatocyte canalicular membrane mediated by a 110-kDa glycoprotein binding ATP and bile salt. J Biol Chem 266: 18920-18926
31. Müller M, Mayer R, Hero U and Keppler D (1994a) ATP-dependent transport of amphiphilic cations across the hepatocyte canalicular membrane mediated by mdr 1 P-glycoprotein. FEBS Lett 343: 168-172
32. Müller M, Mittenbühler K, Mayer R, Wallstab A, Silverman JA, Thorgeiersson SS and Keppler D (1994b) ATP-dependent transport of amphiphilic cations across the canalicular membrane mediated by P-glycoprotein. In Transport in the Liver. Keppler D and Jungermann K (eds). pp 156-165, Academic Publishers: Dordrecht
33. Nicholson DW, Klemba MW, Rasper DM, Metters KM, Zamboni RJ and Ford-Hutchinson RW (1992) Purification of human leukotriene C4 synthase from dimethylsulfoxide-differentiated U937 cells. Eur J Biochem 209: 725-734
34. Nishida T, Gatmaitan Z, Che MX and Arias IM (1991) Rat liver canalicular membrane vesicles containing an ATP-dependent bile acid transport system. Proc Natl Acad Sci USA 88: 6590-6594
35. Pearce HL, Safa AR, Bach NJ, Winzer MA, Cirtain MC and Beck WT (1989) Essential features of the P-glycoprotein pharmacophore as defined by a series of reserpine analogs modulate multidrug resistance. Proc Natl Acad Sci USA 86: 5128-5132
36. Pennock GD, Dalton WS, Roeske WR, Appleton CP, Mosley K, Plezia P, Miller TP and Salmon SE (1991) Systemic toxic effects associated with high-dose verapamil infusion and chemotherapy administration. J Natl Cancer Inst 83: 105-110
37. Roninson IB, Chin JE, Choi K, Gros P, Housman DE, Fojo A, Shen D-W, Gottesman MM and Pastan I (1986) Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci USA 83: 4538-4542
38. Schinkel AH, Smit JJM, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Mol CAAM, van der Valk MA, Robanus-Maandag EC, le Riele HP, Berns AJM and Borst P (1994) Disruption of the mouse mdr 1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77: 491-502
39. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I and Willingham MC (1987) Cellular localisation of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 84: 7735-7738
40. Tsuruo T, Iida H, Tsukagoshi S and Sakurai Y (1981) Overcoming of vincristine resistance in P833 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41: 1967-1972
41. Twentyman PR (1992) Cyclosporins as multidrug resistance modifiers. Biochem Pharmacol 43: 109-117
42. Watanabe T, Tsuge H, Oh-Hara T, Naito M and Tsuruo T (1995) Comparative study on reversal efficiency of SDZ PSC 833, cyclosporin A and verapamil on multidrug resistance in vitro and in vivo. Acta Oncol 34: 235-241
43. Yang CP-H, Cohen D, Greenberger LM, Hsu SI-H and Horwitz SB (1990) Differential transport properties of two mdr gene products are distinguished by progesterone. J Biol Chem 265: 10282-1028